ASX - By Stock
|
PAR |
Re:
PAR - Broker Data
|
|
Gan_Gans
|
56 |
18K |
2 |
10/08/25 |
10/08/25 |
ASX - By Stock
|
56
|
18K
|
2
|
|
ASX - By Stock
|
PER |
Re:
Ann: New Preclinical Data Reported for HMBD-002 in Breast Cancer
|
|
Gan_Gans
|
25 |
6.1K |
3 |
07/08/25 |
07/08/25 |
ASX - By Stock
|
25
|
6.1K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
The Probability of Success
|
|
Gan_Gans
|
46 |
12K |
4 |
05/08/25 |
05/08/25 |
ASX - By Stock
|
46
|
12K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
The Probability of Success
|
|
Gan_Gans
|
46 |
12K |
3 |
04/08/25 |
04/08/25 |
ASX - By Stock
|
46
|
12K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar Presentation
|
|
Gan_Gans
|
74 |
23K |
1 |
01/08/25 |
01/08/25 |
ASX - By Stock
|
74
|
23K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar Presentation
|
|
Gan_Gans
|
74 |
23K |
2 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
74
|
23K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar Presentation
|
|
Gan_Gans
|
74 |
23K |
9 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
74
|
23K
|
9
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar Presentation
|
|
Gan_Gans
|
74 |
23K |
8 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
74
|
23K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Investor Webinar Presentation
|
|
Gan_Gans
|
74 |
23K |
6 |
31/07/25 |
31/07/25 |
ASX - By Stock
|
74
|
23K
|
6
|
|
ASX - By Stock
|
BOE |
Re:
Ann: Board and Management Transition
|
|
Gan_Gans
|
52 |
25K |
2 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
52
|
25K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: June 2025 Quarterly Activities Report & Appendix 4C
|
|
Gan_Gans
|
9 |
3.8K |
2 |
29/07/25 |
29/07/25 |
ASX - By Stock
|
9
|
3.8K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
This peer is 34x PAR (!!) We need better street coverage!
|
|
Gan_Gans
|
53 |
19K |
12 |
23/07/25 |
23/07/25 |
ASX - By Stock
|
53
|
19K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Chart
|
|
Gan_Gans
|
4.9K |
4.1M |
5 |
10/07/25 |
10/07/25 |
ASX - By Stock
|
4.9K
|
4.1M
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Not Recruiting-Regulatory Requirements
|
|
Gan_Gans
|
23 |
5.4K |
2 |
02/07/25 |
02/07/25 |
ASX - By Stock
|
23
|
5.4K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Secures US$27M to Advance Phase 3 OA Trial
|
|
Gan_Gans
|
133 |
48K |
1 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
133
|
48K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
4 |
01/07/25 |
01/07/25 |
ASX - By Stock
|
1.6K
|
554K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: US Sites Activated and Patients Consented
|
|
Gan_Gans
|
19 |
5.3K |
7 |
30/06/25 |
30/06/25 |
ASX - By Stock
|
19
|
5.3K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: US Sites Activated and Patients Consented
|
|
Gan_Gans
|
19 |
5.3K |
4 |
30/06/25 |
30/06/25 |
ASX - By Stock
|
19
|
5.3K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Strengthens OA Pipeline with Strategic Acquisition
|
|
Gan_Gans
|
103 |
30K |
4 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
103
|
30K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm Strengthens OA Pipeline with Strategic Acquisition
|
|
Gan_Gans
|
103 |
30K |
8 |
27/06/25 |
27/06/25 |
ASX - By Stock
|
103
|
30K
|
8
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron licenses HMBD-002 from Hummingbird Bioscience
|
|
Gan_Gans
|
69 |
22K |
1 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
69
|
22K
|
1
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron licenses HMBD-002 from Hummingbird Bioscience
|
|
Gan_Gans
|
69 |
22K |
5 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
69
|
22K
|
5
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron licenses HMBD-002 from Hummingbird Bioscience
|
|
Gan_Gans
|
69 |
22K |
9 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
69
|
22K
|
9
|
|
ASX - By Stock
|
PER |
Re:
Ann: Percheron licenses HMBD-002 from Hummingbird Bioscience
|
|
Gan_Gans
|
69 |
22K |
7 |
26/06/25 |
26/06/25 |
ASX - By Stock
|
69
|
22K
|
7
|
|
ASX - By Stock
|
BMN |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
38 |
14K |
0 |
24/06/25 |
24/06/25 |
ASX - By Stock
|
38
|
14K
|
0
|
|
ASX - By Stock
|
BMN |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
38 |
14K |
4 |
24/06/25 |
24/06/25 |
ASX - By Stock
|
38
|
14K
|
4
|
|
ASX - By Stock
|
BMN |
Re:
Ann: Trading Halt
|
|
Gan_Gans
|
38 |
14K |
3 |
24/06/25 |
24/06/25 |
ASX - By Stock
|
38
|
14K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
|
|
Gan_Gans
|
56 |
22K |
2 |
23/06/25 |
23/06/25 |
ASX - By Stock
|
56
|
22K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Phase 3 Knee OA Trial Begins, Site Live, Patient Consented
|
|
Gan_Gans
|
56 |
22K |
2 |
23/06/25 |
23/06/25 |
ASX - By Stock
|
56
|
22K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
This peer is 34x PAR (!!) We need better street coverage!
|
|
Gan_Gans
|
53 |
19K |
4 |
22/06/25 |
22/06/25 |
ASX - By Stock
|
53
|
19K
|
4
|
|
ASX - By Stock
|
JMS |
Re:
$0.30c imminent
|
|
Gan_Gans
|
52 |
23K |
2 |
20/06/25 |
20/06/25 |
ASX - By Stock
|
52
|
23K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
4 |
19/06/25 |
19/06/25 |
ASX - By Stock
|
1.6K
|
554K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Chair's Address to Shareholders
|
|
Gan_Gans
|
111 |
46K |
1 |
19/06/25 |
19/06/25 |
ASX - By Stock
|
111
|
46K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Chair's Address to Shareholders
|
|
Gan_Gans
|
111 |
46K |
1 |
19/06/25 |
19/06/25 |
ASX - By Stock
|
111
|
46K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Chair's Address to Shareholders
|
|
Gan_Gans
|
111 |
46K |
0 |
18/06/25 |
18/06/25 |
ASX - By Stock
|
111
|
46K
|
0
|
|
ASX - By Stock
|
BMN |
Re:
BMN General Discussion
|
|
Gan_Gans
|
151 |
58K |
2 |
18/06/25 |
18/06/25 |
ASX - By Stock
|
151
|
58K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
0 |
10/06/25 |
10/06/25 |
ASX - By Stock
|
1.6K
|
554K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
outcomes of the meeting on 29 may
|
|
Gan_Gans
|
103 |
38K |
8 |
30/05/25 |
30/05/25 |
ASX - By Stock
|
103
|
38K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
1 |
26/05/25 |
26/05/25 |
ASX - By Stock
|
1.6K
|
554K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
5 |
24/05/25 |
24/05/25 |
ASX - By Stock
|
1.6K
|
554K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
4 |
24/05/25 |
24/05/25 |
ASX - By Stock
|
1.6K
|
554K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
14 |
24/05/25 |
24/05/25 |
ASX - By Stock
|
1.6K
|
554K
|
14
|
|
ASX - By Stock
|
PAR |
Re:
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose
|
|
Gan_Gans
|
58 |
19K |
5 |
21/05/25 |
21/05/25 |
ASX - By Stock
|
58
|
19K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose
|
|
Gan_Gans
|
58 |
19K |
3 |
21/05/25 |
21/05/25 |
ASX - By Stock
|
58
|
19K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
This stock could have something close to a cure for osteoarthritis. Don’t let it hide under your nose
|
|
Gan_Gans
|
58 |
19K |
5 |
21/05/25 |
21/05/25 |
ASX - By Stock
|
58
|
19K
|
5
|
|
ASX - By Stock
|
JMS |
Re:
Ann: Jupiter welcomes Exxaro as prospective partner & shareholder
|
|
Gan_Gans
|
129 |
54K |
7 |
15/05/25 |
15/05/25 |
ASX - By Stock
|
129
|
54K
|
7
|
|
ASX - By Stock
|
JMS |
Re:
Ann: Jupiter welcomes Exxaro as prospective partner & shareholder
|
|
Gan_Gans
|
129 |
54K |
4 |
14/05/25 |
14/05/25 |
ASX - By Stock
|
129
|
54K
|
4
|
|
ASX - By Stock
|
JMS |
Re:
Ann: Jupiter welcomes Exxaro as prospective partner & shareholder
|
|
Gan_Gans
|
129 |
54K |
1 |
14/05/25 |
14/05/25 |
ASX - By Stock
|
129
|
54K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Where are we on a deal?
|
|
Gan_Gans
|
1.6K |
554K |
4 |
06/05/25 |
06/05/25 |
ASX - By Stock
|
1.6K
|
554K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Notice of General Meeting/Proxy Form
|
|
Gan_Gans
|
91 |
28K |
0 |
01/05/25 |
01/05/25 |
ASX - By Stock
|
91
|
28K
|
0
|
|